Crescent Capital Partners
Jennifer Tang is a Chartered Accountant with extensive experience in fund management and compliance. Currently serving as Fund Controller at Crescent Capital Partners since January 2013, Jennifer manages a team and oversees fund compliance reporting to various government entities, cash management, investor reporting, and preparation of annual audited financial accounts. Prior to this role, Jennifer held positions as Fund Accountant and Junior Accountant, and gained valuable customer service experience as a Sales Assistant at Alannah Hill. Jennifer also completed an internship at Omniwealth Services Pty Ltd, contributing to wealth advisory services. Jennifer holds a Bachelor of Commerce degree in Accounting and Finance from Western Sydney University.
This person is not in the org chart
This person is not in any teams
Crescent Capital Partners
Crescent Capital Partners (Crescent) is a Sydney-based private equity firm investing in middle-market companies located in Australia and New Zealand with enterprise values between A$100 million and A$500 million. Crescent was formed in 2000 and has established itself as one of Australasia’s leading middle market private equity firms with its last three funds ranked as top quartile global funds (measured in either USD or AUD), as measured by Cambridge Associates. Crescent’s investment focus is on high-growth companies and sectors, or in industries that are undergoing structural change or that lend themselves to consolidation. Crescent’s role is to accelerate and support the senior management teams of these businesses in reaching their aspirational targets and goals. Crescent has a differentiated investment process that combines thematic and proprietary deal sourcing, with a disciplined and analytical approach to investing and a proactive approach to driving value at portfolio companies. Crescent has particular experience and skills in financial services, healthcare, branded and industrial businesses. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made in the past 10 years. Crescent has had a strong track record in delivering superior returns to investors through successful exits. Crescent is now investing our $1 billion Crescent VII (2023 vintage).